bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.10.30.685514

Glycation enhances protein association with lipid bilayer membranes

Barletti, B.·Paracini, N.·Fragneto, G.·Alcaraz, J.-P.·Nelson, A.·VILGRAIN, I.·Maccarini, M.·Martin, D. K.
View original source ↗Export metadata ↓

Abstract

Glycation is a non-enzymatic post-translational modification that leads to the formation of advanced glycation end-products (AGEs), which accumulate in the blood-stream under chronic hyperglycemia and are implicated in diabetes-related pathologies. While glycated proteins such as albumin or hemoglobin are widely used as biomarkers for glycemic control, the structural and chemical changes induced by glycation may also alter their interactions with lipid interfaces, including cellular membranes and lipoproteins, potentially affecting their biological distribution and diagnostic detectability. In this study, we investigated how glycation influences the interaction of bovine serum albumin (BSA) with supported lipid bilayers (SLBs) of different compositions, used as model systems to replicate the diversity of membrane surface charges and fluidity. Using neutron reflectometry (NR), we compared the membrane association of BSA and a chemically-enhanced glycated form of BSA (gBSA), focusing on nanostructural changes at the bilayer interface. Our results showed negligible interaction of either proteins with zwitterionic or cationic membranes. In contrast, both BSA and gBSA exhibited significant binding to negatively charged bilayers, with glycation significantly amplifying this interaction. Quantitatively, the membrane-associated protein volume fraction increased from 0.11 (BSA) to 0.17 (gBSA), suggesting that glycation modifies the proteins surface properties in ways that promote stronger lipid interactions with negatively charged membranes. These findings suggest that glycation not only affects protein structure but also modulates protein-membrane affinity in a lipid-dependent manner. This has important implications for the bioavailability and behavior of glycated albumin in the bloodstream, potentially influencing the accuracy of clinical assays and contributing to membrane-related pathophysiology in diabetes. Our work highlights the need for a deeper understanding of glycation-induced changes in protein-lipid interactions and their consequences for biomarker reliability and disease mechanisms. Graphical TOC Entry O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=82 SRC="FIGDIR/small/685514v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@150e71aorg.highwire.dtl.DTLVardef@749b35org.highwire.dtl.DTLVardef@179f468org.highwire.dtl.DTLVardef@19cfe8e_HPS_FORMAT_FIGEXP M_FIG C_FIG

Source connections

Explore related subjects

biophysicsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Barletti, B., Paracini, N., Fragneto, G., Alcaraz, J.-P., Nelson, A., VILGRAIN, I., Maccarini, M., Martin, D. K.. 2025-10-31. Glycation enhances protein association with lipid bilayer membranes. https://doi.org/10.1101/2025.10.30.685514

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Design of colipids with controlled lateral distance of head group moieties for targeting strategies in the field of lipid-based nanoparticles

Lipid nanoparticles and liposomes are nanoparticle drug formulations which are firmly established in clinics. In order to expand their application and improve efficacy, surface modifications can be a key strategy, especially for cell specific targeting. Targeting can be achieved by integrating ligand functionalized lipids or lipidoids on the nanoparticle surface. In this case, not solely the targeting ligand itself, but also the structure of the whole targeting lipid/lipidoid can affect the interaction of the targeting ligand with the binding motive on cells. Especially, distal spacer structures between lipid anchor and ligand unit, often composed of polyethylene glycol chains, provide a certain distance of the ligand from the nanoparticle surface. A concept which is currently neglected is the control of the lateral distance between ligand structures on the nanoparticle. Herein we investigated the possibility to design lipidoids with a lateral spacer composed of polyethylene glycol units. We synthesized and characterized different lipidoids which provide a primary amine in the head group for possible ligand coupling. In our model lipidoids the head groups were functionalized with a paramagnetic probe to apply electron paramagnetic resonance (EPR) methods for the characterization of the lipidoid interaction with model nanoparticles, in our case liposomes. Continuous wave EPR was used to study the efficiency of the novel lipidoids to integrate into lipid bilayers of model liposomes, which was shown to depend on lipidoid structure and liposome composition. Furthermore, using double electron-electron resonance (DEER), we observed lipidoid conformational changes occurring upon integration into liposomes.

biophysics↗
bioRxiv2026

Binding mechanisms of therapeutic antibodies to human claudin-18.2

Claudin-18.2 (CLDN18.2) is a tight junction component with highly restricted expression in the paracellular space of nonmalignant gastric epithelial cells. It becomes accessible on tumor cell surface during malignant transformation, making CLDN18.2 an attractive target for targeted therapies against gastric cancer. Recently, zolbetuximab has become the first FDA-approved monoclonal antibody that targets CLDN18.2 in advanced gastric cancer, and others like osemitamab have entered phase 3 clinical trials. However, the high-resolution structure of CLDN18.2 is lacking, and how CLDN18.2 is recognized by therapeutic antibodies remains undefined. Here, we report cryo-EM structures of human claudin-18.2 (hCLDN18.2) in complex with the Fab fragments of zolbetuximab and osemitamab, revealing the structure of hCLDN18.2 and its binding mechanism to the therapeutic antibodies. Further analyses reveal that three residues in the first extracellular loop of hCLDN18.2 that are different from human claudin-18.1 (hCLDN18.1) play a critical role in antibody binding. Our data elucidate the structural basis for selective binding of therapeutic antibodies to hCLDN18.2, which should aid rational design of next-generation immunotherapies targeting hCLDN18.2.

biophysics↗
bioRxiv2026

Structural relationships between the SLC12 cotransporter C-terminal domain, universal stress proteins and adenylating enzymes

Several SLC12 cotransporters bind ATP in a cytoplasmic C-terminal domain (CTD). We analysed 16,192 CTD-containing SLC12 sequences and compared 42,845 representative structures to examine the relationship between this nucleotide site, universal stress proteins (USPs) and adenylating enzymes. In phosphorylated NKCC1, D891 and D927 lie near the ATP phosphate chain, while R801 and K889 form a basic phosphate-binding clamp. NKCC1 retains this arrangement, whereas KCC paralogs replace or lose several corresponding groups. In structural comparisons with USP and adenylating-enzyme references, both CTD lobes score between universal stress proteins and EC-annotated domains, and the two lobes form separate lineages that include bacterial transporters. Lobe-specific and nucleotide-frame comparisons place ATP in the corresponding structural region used for -phosphate chemistry by catalytic members of this fold. Published work on UspG provides a precedent for protein-bound AMP in a natural USP. In the examined SLC12 structures and USP models, candidate protein hydroxyls lack an in-line geometry for attack at ATP P. Protein adenylation would require a change in protein or nucleotide geometry, or a different acceptor. These results define a structural basis for testing conditional protein adenylation at SLC12 nucleotide sites. The required evidence is a covalent protein-AMP adduct, identification of its acceptor and measurement of the expected pyrophosphate coproduct, with soluble nucleotide analysis to distinguish accompanying ATP reactions.

biophysics↗